Peripheral S-phase T cells in HIV disease have a central memory phenotype and rarely have evidence of recent T cell receptor engagement

J Infect Dis. 2005 Jul 1;192(1):62-70. doi: 10.1086/430620. Epub 2005 May 26.

Abstract

Heightened proliferation and death of T lymphocytes may play a key role in human immunodeficiency virus (HIV) pathogenesis; however, the mechanism that mediates this effect and the phenotype of the proliferating T cells have not been clearly determined. We assessed S-phase cell frequencies and phenotype by ex vivo bromodeoxyuridine incorporation and flow-cytometric analysis in a group of 35 HIV-infected individuals. Frequencies of S-phase T cells were increased in HIV disease and were related to plasma HIV RNA levels but not to CD4 cell, total T cell, or total lymphocyte counts. S-phase cells were phenotypically defined as "central memory" cells (CD45RO+CD62L+CCR7+). Although activated (CD38+), S-phase cells lacked CD69 expression, rarely expressed CD25, and were not overrepresented among HIV-specific cells, as might have been expected if these cells had recently been activated by HIV antigens. Thus, in HIV infection, central memory T cells may be highly susceptible to bystander mechanisms of immune activation, leading to S-phase entry.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Antigens, CD / physiology
  • Antiretroviral Therapy, Highly Active
  • Bromodeoxyuridine
  • Cell Proliferation
  • HIV Infections / immunology*
  • Humans
  • Immunologic Memory / physiology*
  • Lymphocyte Activation
  • Lymphocyte Count
  • Phenotype
  • Receptors, Antigen, T-Cell / physiology*
  • S Phase / immunology*
  • T-Lymphocytes / immunology*
  • Virus Replication / physiology

Substances

  • Antigens, CD
  • Receptors, Antigen, T-Cell
  • Bromodeoxyuridine